Viewing Study NCT06615050

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search All Studies All Organizations Report Bug

Ignite Creation Date: 2025-12-24 @ 4:58 PM

Ignite Modification Date: 2025-12-24 @ 4:58 PM

Study NCT ID: NCT06615050

Status: RECRUITING

Last Update Posted: 2025-12-16

First Post: 2024-09-06

Is Possible Gene Therapy: False

Has Adverse Events: False

Brief Title: A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Sponsor: Incyte Corporation

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module